Fungal β-glucan interacts with vitronectin and stimulates tumor necrosis factor alpha release from macrophages

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3548-3554

  Olson, Eric J ^a   Standing, Joseph E ^a   Griego Harper, Natalie ^a   Hoffman, Orleen A ^a   Limper, Andrew H ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; TUMOR NECROSIS FACTOR ALPHA; VITRONECTIN;

ANIMAL CELL; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL VIABILITY; ENDOTHELIUM CELL; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE FUNCTION; MEDIATOR RELEASE; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; RABBIT;

EID: 0029849098     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3548-3554.1996     Document Type: Article

References (58)

1. Abel, G., and J. K. Czop. 1992. Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-lβ. Int. J. Immunopharmacol. 14:1363-1373.
2. Beutler, B., I. W. Milsark, and A. C. Cerami. 1985. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871.
3. Castro, M., J. A. Bjoraker, M. S. Rohrbach, and A. H. Limper. 1996. Inflammatory mediators released by monocytes challenged with Candida albicans. Inflammation 20:109-124.
4. Castro, M., T. I. Morgenthaler, O. A. Hoffman, M. S. Rohrbach, and A. H. Limper. 1993. Pneumocystis carinii induces the release of arachidonic acid and its metabolites from alveolar macrophages. Am. J. Respir. Cell. Mol. Biol. 9:73-81.
5. Castro, M., N. V. Ralston, T. I. Morgenthaler, M. S. Rohrbach, and A. H. Limper. 1994. Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect. Immun. 62:3138-3145.
6. Cross, C. E., and G. I. Bancroft. 1995. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and β-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect. Immun. 63:2604-2611.
7. Czop, J. K., and K. F. Austen. 1985. Generation of leukotrienes by human monocytes upon stimulation of their β-glucan receptor during phagocytosis. Proc. Natl. Acad. Sci. USA 82:2751-2755.
8. Daum, T., and M. S. Rohrbach. 1992. Activation of alveolar macrophage arachidonic acid metabolism by paniculate β-1,3-glucan. FEBS Lett. 309:119-122.
9. Ezekowitz, R. A. B., D. J. Williams, H. Kozial, M. Y. K. Armstrong, A. Warner, F. F. Richards, and R. M. Rose. 1991. Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature (London) 351:155-158.
10. Fels, A. O., and Z. A. Cohn. 1986. The alveolar macrophage. J. Appl. Physiol. 60:353-369.
11. Goldman, D., S. C. Lee, and A. Casadevall. 1994. Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect. Immun. 62:4755-4761.
12. Hayman, E. G., M. D. Pierschbacher, S. Suzuki, and E. Ruoslahti. 1985. Vitronectin: a major cell attachment-promoting protein in fetal bovine serum Exp. Cell Res. 160:245-258.
13. Hoffman, O. A., E. J. Olson, and A. H. Limper. 1993. Fungal β-glucans modulate macrophage release of tumor necrosis factor-α in response to bacterial lipopolysaccharide. Immunol. Lett. 37:19-25.
14. Hoffman, O. A., J. E. Standing, and A. H. Limper. 1993. Pneumocystis carinii stimulates tumor necrosis factor-α release from alveolar macrophages through a β-glucan-mediated mechanism. J. Immunol. 150:3932-3940.
15. Hyers, T. M., S. M. Tricomi, P. A. Dettenmeier, and A. A. Fowler. 1991. Tumor necrosis factor levels in serum and bronchoalveolar lavage fluid of patients with the adult respiratory distress syndrome. Am. Rev. Respir. Dis. 144:268-271.
16. Ito, H., S. Yamamoto, S. Kuroda, H. Sakamoto, J. Kajihara, T. Kiyota, H. Hayashi, M. Kato, and M. Seko. 1986. Molecular cloning and expression in Escherichia coli of the cDNA coding for rabbit tumor necrosis factor. DNA 5:149-156.
17. Jaattela, M. 1991. Biologic activities and mechanisms of action of tumor necrosis factor-α/cachectin. Lab. Invest. 64:724.
18. Janusz, M. J., K. F. Austen, and J. K. Czop. 1987. Lysosomal enzyme release from human monocytes by paniculate activators is mediated by β-glucan inhibitable receptors. J. Immunol. 138:3897-3901.
19. Janusz, M.J., K. F .Austen, and J.K. Czop. 1988. Phagocytosis of heat-killed blastospores of Candida albicans by human monocyte beta-glucan receptors. Immunology 65:181-185.
20. Kadish, J. L., C. C. Choi, and J. K. Czop. 1986. Phagocytosis of unopsonized zymosan particles by trypsin-sensitive and beta-glucan-inhibitable receptors on bone marrow-derived murine macrophages. Immunol. Res. 5:129-138.
21. Kimura, A., R. L. Sherwood, and G. F. Goldstein. 1983. Glucan alteration of pulmonary antibacterial defense. J. Reticulendothel. Soc. 34:1-11.
22. Kohl, S., L. K. Pickering, and N. R. Diluzio. 1979. Inhibition of human monocyte-macrophage and lymphocyte cytotoxicity to herpes simplex-infected cells by glucan. J. Immunol. Methods 29:361-368.
23. Kokoshis, P. L., D. L. Williams, J. A. Cook, and N. R. DiLuzio. 1978. Increased resistance to Staphylococcus aureus infection and enhancement in serum lysozyme activity by glucan. Science 199:1340-1342.
24. Kramer, S. M., and M. E. Carver. 1986. Serum-free in vitro bioassay for the detection of tumor necrosis factor. J. Immunol. Methods 93:201-206.
25. Kunkel, S. L., S. W. Chensue, and S. H. Phan. 1986. Prostaglandins as endogenous mediators of interleukin-1 production. J. Immunol. 127:186-192.
26. Kunkel, S. L., M. Spengler, G. Kwon, M. A. May, and D. G. Remick. 1988. Production and regulation of tumor necrosis factor alpha: a cellular and molecular analysis. Methods Achiev. Exp. Pathol. 33:240-259.
27. 2. Biochem. Biophys. Res. Commun. 137:404-410.
28. Le, J., and J. Vilcek. 1987. Biology of disease. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab. Invest. 56:234-248.
29. Limper, A. H. 1995. Adhesive glycoproteins in the pathogenesis of Pneumocystis carinii pneumonia: host defense or microbial offense? J. Lab. Clin. Med. 125:12-13.
30. Limper, A. H., and J. E. Standing. 1994. Vitronectin interacts with Candida albicans and augments organism attachment to the NR8383 macrophage cell line. Immunol. Lett. 42:139-144.
31. Limper, A. H., J. E. Standing, O. A. Hoffman, M. Castro, and L. W. Neese. 1993. Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect. Immun. 61:4302-4309.
32. Lucas, R., S. Magez, R. De Leys, L. Fransen, J. P. Scheerlinck, M. Rampelberg, E. Sablon, and P. De Baetselier. 1994. Mapping the lectin-like activity of tumor necrosis factor. Science 263:814-817.
33. Luo, G., D. W. Niesel, R. A. Shaban, E. A. Grimm, and G. R. Kumpel. 1993. Tumor necrosis factor alpha binding to bacteria: evidence for a high-affinity receptor and alteration of bacterial virulence properties. Infect. Immun. 61:830-835.
34. Manners, D. J., A. J. Masson, and J. C. Patterson. 1973. The structure of a β-(1-3)-D-glucan from yeast cell walls. Biochem. J. 135:19-30.
35. Masur, H., and T. C. Jones. 1978. The interaction in vitro of Pneumocystis carinii with phagocytes and L-cells. J. Exp. Med. 147:157-170.
36. Neese, L. W., J. E. Standing, E. J. Olson, M. Castro, and A. H. Limper. 1994. Vitronectin, fibronectin, and gp120 antibody enhance macrophage release of TNF-alpha in response to Pneumocystis carinii. J. Immunol. 152:4549-4556.
37. Newman, S. L., and L. Gootee. 1992. Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect. Immun. 60:4593-4597.
38. Parker, C. J., R. N. Frame, and M. R. Elstad. 1988. Vitronectin (S-Protein) augments the functional activity of monocyte receptors for IgG and complement C3b. Blood 71:86-93.
39. Patchen, M. L., M. M. D'Alesandro, I. Brook, W. F. Blakely, and T. J. MacVittie. 1987. Glucan: mechanisms involved in its "radioprotective" effect. J. Leukocyte Biol. 42:95-105.
40. Patchen, M. L., N. R. DiLuzio, P. Jacques, and T. J. MacVittie. 1984. Soluble polyglycans enhance recovery from cobalt-60-induced hemopoietic injury. J. Biol. Response Modif. 3:627-633.
41. Patchen, M. L., and T. J. MacVittie. 1986. Hemopoietic effects of intravenous soluble glucan administration. J. Immunopharmacol. 8:407-425.
42. Pesanti, E. L. 1991. Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro. J. Infect. Dis. 163:611-616.
43. 125I-labelled tumor necrosis factor to Pneumocystis carinii and an insoluble cell wall fraction. J. Protozool. 38:28S-29S.
44. Rassmussen, L. T., and R. Seljelid. 1992. Novel immunomodulators with pronounced in vivo effects caused by stimulation of cytokine release. J. Cell. Biochem. 46:60-68.
45. Reynolds, J. A., M. D. Kastello, D. G. Harrington, C. L. Crabbs, C. J. Peters, J. V. Jemski, G. H. Scott, and N. R. DiLuzio. 1980. Glucan-induced enhancement of host resistance to selected infectious diseases. Infect. Immun. 30:51-57.
46. Riggi, S. J., and N. R. DiLuzio. 1961. Identification of a reticuloendothelial stimulating agent in zymosan. Am. J. Physiol. 200:297-302.
47. Sakurai, T., K. Hashimoto, I. Suzuki, N. Ohno, S. Oikawa, A. Masuda, and T. Yadomae. 1992. Enhancement of murine alveolar macrophage functions by orally administered β-glucan. Int. J. Immunopharmacol. 14:821-830.
48. Seljelid, R., J. Bøgwald, J. Hoffman, and O. Larm. 1984. Soluble β-1,3-Dglucan derivative potentiates the cytostatic and cytolytic capacity of mouse peritoneal macrophages in vitro. Immunopharmacology 7:69-83.
49. Sherblom, A. P., J. M. Decker, and A. V. Muchmore. 1988. The lectin-like interaction between recombinant tumor necrosis factor and uromodulin. J. Biol. Chem. 263:5418-5424.
50. Sherwood, E. R., D. L. Williams, R. E. McNamee, E. L. Jones, I. W. Browder, and N. R. DiLuzio. 1987. Enhancement of interleukin-1 and interleukin-2 production by soluble glucan. Int. J. Immunopharmacol. 9:261-267.
51. Suzuki, I., T. Sakurai, K. Hashimoto, S. Oikawa, A. Masuda, M. Ohsawa, and T. Yadomae. 1991. Inhibition of experimental pulmonary metastasis of Lewis lung carcinoma by orally administered β-glucan in mice. Chem. Pharm. Bull. 39:1606-1608.
52. Suzuki, S., M. D. Pierschbacher, E. G. Hayman, K. Nguyen, Y. Ohgren, and E. Ruoslahti. 1984. Domain structure of vitronectin. J. Biol. Chem. 259:15307-15314.
53. Szabo, T., J. L. Kadish, and J. K. Czop. 1995. Biochemical properties of the ligand-binding 20 kDa subunit of the β-glucan receptor on human mononuclear phagocytes. J. Biol. Chem. 270:2145-2151.
54. Thompson, I. M., C. R. Spence, D. L. Lamm, and N. R. DiLuzio. 1987. Immunochemotherapy of bladder carcinoma with glucan and cyclophosphamide. Am. J. Med. Sci. 294:294-300.
55. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. C. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteremia. Nature (London) 330:662-664.
56. Tracey, K. J., S. F. Lowry, T. J. Fahey, J. D. Albert, Y. Fong, D. G. Hesse, B. Beutler, K. R. Manogue, S. Calvano, H. Wei, A. C. Cerami, and G. T. Shires. 1987. Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog. Surg. Gynecol. Obstet. 164:415-422.
57. Waldorf, A. R., S. M. Levitz, and R. D. Diamond. 1984. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J. Infect. Dis. 150:752-760.
58. Yatohgo, T., I. Izumi, H. Kashiwagi, and M. Hayashi. 1988. Novel purification of vitronectin from human plasma by heparin chromatography. Cell Struct. Funct. 13:281-292.